Research Article
Danshen (Salvia miltiorrhiza) Compounds Improve the Biochemical Indices of the Patients with Coronary Heart Disease
Table 4
Biochemical indices after three-month follow-up, median (range), mg/dL.
| | Danshen group () | Placebo group () | values |
| Lipid profile | | | | LDL cholesterol | 98 (82–133) | 123 (94–157) | 0.017 | HDL cholesterol | 62 (49–77) | 50 (49–69) | 0.039 | Total cholesterol | 155 (147–195) | 192 (179–251) | 0.001 | Triglycerides | 101 (80–158) | 121 (84–172) | 0.016 | Apolipoprotein A | 119 (103–143) | 96 (81–123) | 0.023 | Apolipoprotein B | 93 (78–114) | 75 (65–101) | 0.009 | Apolipoprotein E | 8.7 (6.8–10.7) | 7.3 (5.6–8.7) | 0.024 | Lipoprotein (a) | 18 (15–20) | 31 (21–43) | 0.001 | Liver function | | | | Gamma-glutamyl transpeptidase (IU/dL) | 1.6 (1.2–1.8) | 3.1 (2.3–5.2) | 0.001 | Total bilirubin | 0.8 (0.6–1.0) | 0.6 (0.4–0.7) | 0.032 | Indirect bilirubin | 0.6 (0.5–0.8) | 0.4 (0.3–0.5) | 0.025 | Direct bilirubin | 0.2 (0.1–0.3) | 0.3 (0.2–0.4) | 0.037 | Renal function | | | | Uric acid | 4.5 (3.6–5.5) | 5.4 (4.2–6.7) | 0.040 | Risk factor of heart disease | | | | Homocysteine | 14 (11–17) | 24 (20–41) | 0.001 |
|
|